AbbVie aims to add new autoimmune disease options to its pipeline with acquisition of Landos Biopharma
Moderna's next-gen COVID vaccine demonstrates stronger immune response, passing phase 3 trial test
J&J becomes the first to target rare maternal-fetal diseases
J&J receives FDA approval for a combination drug designed to treat PAH
Merck's Keytruda receives approval from European Commission as a continuous treatment for non-small cell lung cancer (NSCLC)
The AIDS Healthcare Foundation urging a compulsory license for GSK's HIV treatment to lower the price in Trinidad and Tobago
Bristol Myers Squibb's Zeposia fails to enter the Crohn's disease market
Eli Lilly's faces an unprecedented demand for their obesity medication, Zepbound
Pfizer's Velsipity may outperform BMS' Zeposia in competitive UC market
AstraZeneca's Imfinzi is the first immunotherapy to extend lives of patients with small cell lung cancer in phase 3 trial
A common microbe in the mouth that travels to the gut may be responsible for the progression of colorectal tumor growth
Immunotherapy could be a way to prevent breast cancer
Epigenetic cancer drugs could destroy colorectal cancer cells
Magnetic stimulation technology approved as a first line add-on therapy for major depressive disorder in adolescent patients
%402x.svg){kind=icon}
.png)
%402x.svg){kind=icon}
